Clinical Trial Update: Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children [Phase 4]

View source ↗

Summary

This Clinical Trial Update reports on the antibody response to a boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in children in a Phase 4 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) (Japanese encephalitis chimeric virus vaccine)

Snippet

Sponsor: Khon Kaen University | Conditions: Japanese Encephalitis | Phase 4 | Status: UNKNOWN